Warframe Trading [PC][LICH][PRICE CHECK] 40% Nukor with ephemera |
- [PC][LICH][PRICE CHECK] 40% Nukor with ephemera
- [PC] [RIVEN] [PRICE CHECK] [WTS]
- [PC] [RIVEN] [PRICE CHECK] [WTS]
- [PC] [Riven] [Price Check] Vectis, Tombfinger, Soma, among others
- [PS4] [Price Check] How much should I sell this for? Thanks
- [WTB][XB1][GT:BMC2005]
- [WTS] [Riven] [PC] [Price Check]
- [RIVEN] [PRICE CHECK] [WTS] [XB1] Plague Keewar Visicitron , Cassowar Scicroniata
- [PS4] [PRC] Halikar advice?
[PC][LICH][PRICE CHECK] 40% Nukor with ephemera Posted: 09 Oct 2020 03:50 AM PDT |
[PC] [RIVEN] [PRICE CHECK] [WTS] Posted: 09 Oct 2020 11:58 AM PDT |
[PC] [RIVEN] [PRICE CHECK] [WTS] Posted: 09 Oct 2020 01:12 PM PDT |
[PC] [Riven] [Price Check] Vectis, Tombfinger, Soma, among others Posted: 09 Oct 2020 05:06 AM PDT |
[PS4] [Price Check] How much should I sell this for? Thanks Posted: 09 Oct 2020 04:48 AM PDT |
Posted: 09 Oct 2020 04:22 AM PDT |
[WTS] [Riven] [PC] [Price Check] Posted: 08 Oct 2020 10:52 PM PDT |
[RIVEN] [PRICE CHECK] [WTS] [XB1] Plague Keewar Visicitron , Cassowar Scicroniata Posted: 09 Oct 2020 01:19 AM PDT I'm not sure how to upload pictures on mobile, so I'll list the stats for each. I got these years ago, but never got around to actually selling or using them. Help me out, yeah? Plague Keewar +10.8% Melee Damage +7.4% Slash +2.6% Damage to Corpus Cassowar +20.5% Melee Damage +16.1% Slash +7.3% Attack Speed -13.3% Critical Chance for Slide Attack [link] [comments] |
Posted: 08 Oct 2020 09:53 PM PDT +281.6% melee damage +342.8% critical chance (x2 for heavy attack) -80% critical chance for slide attack This roll sounds AMAZING but it's for Halikar which frankly, I don't know much about at all.... I mean it's a throwing weapon right? Not sure about this one. [link] [comments] |
You are subscribed to email updates from The hub for Warframe trading. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
No comments:
Post a Comment